Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Blockade of the inflammatory cytokine tumor necrosis factor (TNF) in depressed patients with increased inflammation has been associated with decreased depressive symptoms. Nevertheless, the impact of TNF blockade on sleep in depressed patients has not been examined. Accordingly, sleep parameters were measured using polysomnography in 36 patients with treatment resistant major depression at baseline and 2 weeks after 3 infusions (week 8) of either the TNF antagonist infliximab (n=19) or placebo (n=17). Markers of inflammation including c-reactive protein (CRP) and TNF and its soluble receptors were assessed along with depression measured by the 17-item Hamilton Depression Rating Scale. No differences in sleep parameters were found as a function of infliximab treatment over time. Nevertheless, Wake After Sleep Onset (WASO), the spontaneous arousal index and sleep period time significantly decreased, and sleep efficiency significantly increased, from baseline to week 8 in infliximab-treated patients with high (CRP>5mg/L)(n=9) versus low inflammation (CRP≤5mg/L)(n=10), controlling for changes in scores of depression. Stage 2 sleep also significantly decreased in infliximab-treated patients with high versus low inflammation. Decreases in soluble TNF receptor 1 significantly correlated with decreases in WASO and increases in sleep efficiency in infliximab-treated subjects with high inflammation. Placebo-treated subjects exhibited no sleep changes as a function of inflammation, and no correlations between inflammatory markers and sleep parameters in placebo-treated patients were found. These data suggest that inhibition of inflammation may be a viable strategy to improve sleep alterations in patients with depression and other disorders associated with increased inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401 · cited 2×
“A CRP concentration of 2 mg/L was chosen because it is the central value in the “medium” relative risk category of inflammation (1–3 mg/L) recommended by the American Heart Association and the Centers for Disease Control and Prevention (Pearson et al. 2003).”
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 4×
“Interestingly, TNF is reliably elevated in depressed patients (Dowlati et al. 2010), and TNF blockade has been shown to have antidepressant activity in inflammatory and autoimmune diseases including psoriasis and Crohn’s disease (Persoons et al.”
InfluentialInflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 4×
“Markers of inflammation, including inflammatory cytokines and their receptors, acute phase proteins such as c-reactive protein (CRP), chemokines, and adhesion molecules have been found to be elevated in a significant proportion of depressed patients in multiple studies (Dowlati et al. 2010; Miller et al. 2009).”
InfluentialSelf-citationChung, E. S., Packer, M., Lo, K. H., Fasanmade, A. A., & Willerson, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000077913.60364.d2 · Cited by 1,644 · cited 1×
“Because plasma TNF exhibited a dramatic increase at week 8 [consistent with assay detection of partially saturated TNF-infliximab homotrimers (Chung et al. 2003)], TNF was not included in these models.”
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617 · cited 16×
“The study was registered at clinicaltrials.gov (NCT00463580) in April 2007, and the CONSORT diagram has been previously published (Raison et al. 2013).”
InfluentialSelf-citationParoxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120 · cited 1×
“Poor sleep quality before and during IFN-alpha treatment has been found to predict the development of IFN-alpha-induced depression, which occurs in up to 30–50% of patients depending on the dose (Capuron et al. 2002; Franzen et al. 2010; Musselman et al. 2001; Prather et al. 2009).”
Self-citationTsuno, N., Besset, A., & Ritchie, K. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1008 · Cited by 1,084
Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069 · cited 2×
“Interestingly, TNF is reliably elevated in depressed patients (Dowlati et al. 2010), and TNF blockade has been shown to have antidepressant activity in inflammatory and autoimmune diseases including psoriasis and Crohn’s disease (Persoons et al. 2005; Tyring et al. 2006).”
TRIVEDI, M. H., RUSH, A. J., IBRAHIM, H. M., CARMODY, T. J., BIGGS, M. M., SUPPES, T., CRISMON, M. L., SHORES-WILSON, K., TOPRAC, M. G., DENNEHY, E. B., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291703001107 · Cited by 968 · cited 3×
“All participants were required to have experienced moderate treatment resistance in the current depressive episode, as determined by a score of 2 or higher on the Massachusetts General Hospital Staging method for treatment resistance (Petersen et al. 2005), and to exhibit moderate severity of depression as determined…”
InfluentialSleep Deprivation and Activation of Morning Levels of Cellular and Genomic Markers of Inflammation
Irwin, M. R. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.16.1756 · Cited by 850 · cited 2×
“…architecture, a number of studies have demonstrated that sleep deprivation can increase inflammatory markers both at the protein and molecular level, leading to increases of IL-6 and activation of the inflammatory signaling molecule nuclear factor kappa B (Irwin et al. 2006; Irwin et al. 2008).”
Sleep disorders as core symptoms of depression
Nutt, D., Wilson, S., & Paterson, L. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.3/dnutt · Cited by 839
Capuron, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00407-9 · Cited by 797 · cited 1×
“Poor sleep quality before and during IFN-alpha treatment has been found to predict the development of IFN-alpha-induced depression, which occurs in up to 30–50% of patients depending on the dose (Capuron et al. 2002; Franzen et al. 2010; Musselman et al. 2001; Prather et al. 2009).”
How (and why) the immune system makes us sleep
Imeri, L., & Opp, M. R. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2576 · Cited by 710 · cited 2×
“One pathophysiologic mechanism that may be involved in some of the sleep changes found in depression is inflammation (Benedict et al. 2009; Imeri and Opp 2009; Irwin et al. 2008; Krueger 2008; Krueger et al. 2001; Motivala et al. 2005; Opp 2005).”
D'Mello, C., Le, T., & Swain, M. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3567-08.2009 · Cited by 675 · cited 2×
“There is some evidence to suggest that soluble TNF receptors may be more reliable markers of inflammation than TNF (Schroder et al. 1995) and that sTNFR1 may have a special association with neuroinflammation as well as psychiatric syndromes (Barbosa et al. 2011; D’Mello et al. 2009).”
Brain-immune communication pathways
Quan, N., & Banks, W. A. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.05.005 · Cited by 626 · cited 1×
“…a rich literature describing how inflammatory cytokines including TNF can access the brain including passage through leaky regions in the blood brain barrier, active transport mechanisms and binding to peripheral afferent nerve fibers including the vagus (Miller et al. 2009; Quan and Banks 2007).”
The Role of Cytokines in Sleep Regulation
Krueger, J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786549281 · Cited by 507 · cited 2×
“One pathophysiologic mechanism that may be involved in some of the sleep changes found in depression is inflammation (Benedict et al. 2009; Imeri and Opp 2009; Irwin et al. 2008; Krueger 2008; Krueger et al. 2001; Motivala et al. 2005; Opp 2005).”
Sleep Loss Activates Cellular Inflammatory Signaling
Irwin, M. R., Wang, M., Ribeiro, D., Cho, H. J., Olmstead, R., Breen, E. C., Martinez-Maza, O., & Cole, S. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.004 · Cited by 467 · cited 3×
“One pathophysiologic mechanism that may be involved in some of the sleep changes found in depression is inflammation (Benedict et al. 2009; Imeri and Opp 2009; Irwin et al. 2008; Krueger 2008; Krueger et al. 2001; Motivala et al. 2005; Opp 2005).”
Opp, M. R. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2005.01.002 · Cited by 393
Antidepressants and their effect on sleep
Mayers, A. G., & Baldwin, D. S. (2005) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.726 · Cited by 323 · cited 1×
“These medications especially antidepressants have been consistently shown to increase REM latency and decrease overall time spent in REM sleep (Hendrickse et al. 1994; Kerkhofs et al. 1990; Mayers and Baldwin 2005).”
Wohleb, E. S., McKim, D. B., Shea, D. T., Powell, N. D., Tarr, A. J., Sheridan, J. F., & Godbout, J. P. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.11.029 · Cited by 300
PERSOONS, P., VERMEIRE, S., DEMYTTENAERE, K., FISCHLER, B., VANDENBERGHE, J., VAN OUDENHOVE, L., PIERIK, M., HLAVATY, T., VAN ASSCHE, G., NOMAN, M., et al. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02535.x · Cited by 253 · cited 2×
“Interestingly, TNF is reliably elevated in depressed patients (Dowlati et al. 2010), and TNF blockade has been shown to have antidepressant activity in inflammatory and autoimmune diseases including psoriasis and Crohn’s disease (Persoons et al. 2005; Tyring et al. 2006).”
Dose-dependent effects of endotoxin on human sleep
Mullington, J., Korth, C., Hermann, D. M., Orth, A., Galanos, C., Holsboer, F., & Pollmächer, T. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.278.4.r947 · Cited by 226
Prather, A. A., Vogelzangs, N., & Penninx, B. W. J. H. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.09.018 · Cited by 181
Karson, A., Demirtaş, T., Bayramgürler, D., Balcı, F., & Utkan, T. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12037 · Cited by 143 · cited 2×
“…shown that peripheral administration of infliximab significantly reduces depression and anxiety-like behavior in the chronic mild stress model of depression (Karson et al. 2013), suggesting that stress-induced behavioral changes may be a function of activation of peripheral inflammatory responses.”
Cytokine-induced depression during IFN-α treatment: The role of IL-6 and sleep quality
Prather, A. A., Rabinovitz, M., Pollock, B. G., & Lotrich, F. E. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.07.001 · Cited by 139 · cited 1×
“Poor sleep quality before and during IFN-alpha treatment has been found to predict the development of IFN-alpha-induced depression, which occurs in up to 30–50% of patients depending on the dose (Capuron et al. 2002; Franzen et al. 2010; Musselman et al. 2001; Prather et al. 2009).”
Raison, C. L., Rye, D. B., Woolwine, B. J., Vogt, G. J., Bautista, B. M., Spivey, J. R., & Miller, A. H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.019 · Cited by 116 · cited 13×
“As previously reported in IFN-alpha-treated patients, sleep period time was significantly greater in patients with high versus low inflammation (487.9 SD 50.7 versus 444.1 SD 67.3, respectively, t=−2.09, p=0.045)(Raison et al. 2010).”
InfluentialSelf-citationIncreased plasma levels of soluble TNF receptor I in patients with bipolar disorder.
Barbosa, I. G., Huguet, R. B., Mendonça, V. A., Sousa, L. P., Neves, F. S., Bauer, M. E., & Teixeira, A. L. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0116-z · Cited by 108 · cited 2×
“There is some evidence to suggest that soluble TNF receptors may be more reliable markers of inflammation than TNF (Schroder et al. 1995) and that sTNFR1 may have a special association with neuroinflammation as well as psychiatric syndromes (Barbosa et al. 2011; D’Mello et al. 2009).”
Mehta, D., Raison, C. L., Woolwine, B. J., Haroon, E., Binder, E. B., Miller, A. H., & Felger, J. C. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.04.004 · Cited by 74 · cited 1×
“The subject sample described in this report represent a subset of subjects whose depression scores (HAM-D-17) and peripheral blood gene expression across treatment have been reported on previously (Mehta et al. 2013; Raison et al. 2013).”
Self-citationFranzen, P. L., Buysse, D. J., Rabinovitz, M., Pollock, B. G., & Lotrich, F. E. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.02.011 · Cited by 62 · cited 1×
“Poor sleep quality before and during IFN-alpha treatment has been found to predict the development of IFN-alpha-induced depression, which occurs in up to 30–50% of patients depending on the dose (Capuron et al. 2002; Franzen et al. 2010; Musselman et al. 2001; Prather et al. 2009).”
Fluoxetine in Major Depression: Efficacy, Safety and Effects on Sleep Polygraphic Variables
KERKHOFS, M., RIELAERT, C., MAERTELAER, V. D., LINKOWSKI, P., CZARKA, M., & MENDLEWICZ, J. (1990) · International Clinical Psychopharmacology · doi:10.1097/00004850-199010000-00002 · Cited by 61
Cited by
Sleep health: Reciprocal regulation of sleep and innate immunity
Irwin, M. R., & Opp, M. R. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.148 · Cited by 624
McKim, D. B., Weber, M. D., Niraula, A., Sawicki, C. M., Liu, X., Jarrett, B. L., Ramirez-Chan, K., Wang, Y., Roeth, R. M., Sucaldito, A. D., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.64 · Cited by 365
Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects
Gough, P., & Myles, I. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585880 · Cited by 268
Examining the role of neuroinflammation in major depression
Furtado, M., & Katzman, M. A. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.06.009 · Cited by 192
Boerrigter, D., Weickert, T. W., Lenroot, R., O’Donnell, M., Galletly, C., Liu, D., Burgess, M., Cadiz, R., Jacomb, I., Catts, V. S., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0962-y · Cited by 171
“In clinical trials with individuals with major depression, they showed significant improvement in symptoms [8] after an anti-inflammatory (infliximab) treatment and improved quality of sleep [9], but only in those individuals with elevated inflammation defined as elevated C-reactive protein (CRP) levels.”
Metadata
- Authors
- Weinberger, J. F., Raison, C. L., Rye, D. B., Montague, A. R., Woolwine, B. J., Felger, J. C., Haroon, E., & Miller, A. H.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 47
- Pages
- 193-200
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W2077960328
- Cited by
- 85
- References
- 33
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.